Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Schambye Hans T.
Chief Executive Officer at Damora Therapeutics. Filing since 24 Jun 2021.
CIK 0001825776
Company
Date
Role
Action
Shares
Amount
Of holding
DMRA
Damora Therapeutics, Inc.
2 Jan 2026
Chief Executive Officer
Sold at will
700
$14.97K
13.0%
DMRA
Damora Therapeutics, Inc.
3 Jul 2025
Chief Executive Officer
Sold at will
735
$2.48K
15.5%
DMRA
Damora Therapeutics, Inc.
3 Jan 2025
Chief Executive Officer
Sold at will
1,341
$7.51K
28.3%
DMRA
Damora Therapeutics, Inc.
22 Mar 2022
Chief Executive Officer
Bought
5,000
$10.75K
10.5%
DMRA
Damora Therapeutics, Inc.
9 Nov 2021
Chief Executive Officer
Bought
4,500
$15.75K
10.5%
DMRA
Damora Therapeutics, Inc.
24 Jun 2021
Chief Executive Officer
Bought
3,000
$15.33K
7.5%
6 decisions on file.
